Resources

We explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce ove

To assess for long-term positive effects of buprenorphine treatment (BT) on opioid use disorder (OUD) at a Nishnawbe Aski Nation high school clinic

Collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.

Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other drug use.

Drawing on data from U.S.

This study identified patient profiles in terms of their quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes based on frequent emergency d

This study estimated cost savings from expanding access to substance use disorder (SUD) treatment for persons with opioid use disorders (OUD).

The aim of this study was to examine what drives increases in opioid overdose death among Black Americans based on the experience of key stakeholders.

Take-Home Naloxone (THN) kits may be stored in non-standard conditions, including in vehicles, backpacks, and out of doors.

This paper builds upon the concept of the ‘informed patient’ to explore individuals’ decisions to initiate injectable depot buprenorphine.

Researchers have argued that providing genetic explanations of addiction will reduce stigma, but there has been limited research testing this prediction.

Here, we discuss the tensions that arose in the process of co-designing drug alert templates with health and community workers.

The present study aimed to investigate the effect of zinc supplementation on the probability of relapse (PoR) and mental health (MH) problems in patients with opioid use disorder undergoing MMT.